Quarterly report [Sections 13 or 15(d)]

Earnings Per Share

v3.25.1
Earnings Per Share
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (“EPS”) for the three and three months ended March 31, 2025 and 2024:
Three Months Ended March 31,
2025 2024
(dollars in thousands, except share and per share amounts)
Numerator
Net (loss) income attributable to common stockholders $ (7,254) $ 190 
 
Denominator
Weighted average common shares outstanding - basic 36,334,207  36,279,679 
Dilutive effect of warrants —  135,932 
Dilutive effect of options —  146,408 
Dilutive effect of share-based awards —  236,703 
Weighted average common shares outstanding - diluted 36,334,207  36,798,722 
 
(Loss) earnings per share
Basic $ (0.20) $ 0.01 
Diluted $ (0.20) $ 0.01 
The Company excluded 2.1 million common stock equivalents from diluted EPS related to antidilutive equity instruments during the three months ended March 31, 2025. The Company also excluded 0.2 million of potentially dilutive stock related to options and awards due to the Company being in a net loss position during the three months ended March 31, 2025. The Company excluded 0.1 million common stock equivalents from diluted EPS related to antidilutive equity instruments during the three months ended March 31, 2024. The antidilutive effect during the three months ended March 31, 2025, is primarily attributable to the warrants. During that period, the average stock price of the Company was below the strike price of the warrants, whereas during the three months ended March 31, 2024, the average stock price exceeded the warrants’ strike price.